Nitric oxide and interleukin-1β mediate noradrenergic induced corticotrophin-releasing hormone release in organotypic cultures of rat paraventricular nucleus

Neuroscience

Volumn 165, Issue 4, 2010, Pages 1191-1202

  Hsieh, C H ^a   Li, H Y ^b   Chen, J C ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b OREGON INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

corticotropin releasing factor; IL 1 ; nitric oxide; paraventricular nucleus of rat hypothalamus; stress

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; INTERLEUKIN 1BETA; N(G) NITROARGININE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; NORADRENALIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; HORMONE RELEASE; NERVE CELL CULTURE; NEUROENDOCRINE SYSTEM; NEUROMODULATION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; THALAMUS MIDLINE NUCLEUS;

ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; CORTICOTROPIN-RELEASING HORMONE; ENZYME INHIBITORS; INTERLEUKIN-1BETA; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; NITROARGININE; NITROPRUSSIDE; NOREPINEPHRINE; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, INTERLEUKIN-1; SIGNAL TRANSDUCTION;

EID: 73749087473     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.12.003     Document Type: Article

References (89)

1. Bali B., Ferenczi S., and Kovacs K.J. Direct inhibitory effect of glucocorticoids on corticotrophin-releasing hormone gene expression in neurones of the paraventricular nucleus in rat hypothalamic organotypic cultures. J Neuroendocrinol 20 (2008) 1045-1105
2. Benarroch E.E. Paraventricular nucleus, stress response, and cardiovascular disease. Clin Auton Res 15 (2005) 254-263
3. Berkenbosch F., Van Oers J., and Del Rey A. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science 238 (1987) 524-530
4. Blandino Jr. P., Barnum C.J., and Deak T. The involvement of norepinephrine and microglia in hypothalamic and splenic IL-1β responses to stress. J Neuroimmunol 173 (2006) 87-95
5. Breder C.D., Dinarello C.A., and Saper C.B. Interleukin-1 immunoreactive innervation of the human hypothalamus. Science 240 (1988) 321-324
6. Bredt D.S., Hwang P.M., and Snyder S.H. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 347 (1990) 768-770
7. Bredt D.S. Endogenous nitric oxide synthesis: biological functions and pathophysiology. Free Radic Res 31 (1999) 577-596
8. Brunetti L., Preziosi P., Ragazzoni E., and Vacca M. Involvement of nitric oxide in basal and interleukin-1β-induced CRH and ACTH release in vitro. Life Sci 53 (1993) L219-PL222
9. Bugajski J., Gadek-Michalska A., Glod R., Borycz J., and Bugajski A.J. Blockade of nitric oxide formation impairs adrenergic-induced acth and corticosterone secretion. J Physiol Pharmacol 50 (1999) 327-335
10. Bugajski J., Gadek-Michalska A., and Bugajski A.J. Nitric oxide and prostaglandin systems in the stimulation of hypothalamic-pituitary-adrenal axis by neurotransmitters and neurohormones. J Physiol Pharmacol 55 (2004) 679-703
11. Calabrese V., Mancuso C., Calvani M., Rizzarelli E., Butterfield D.A., and Giuffrida Stella A.M. Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat Rev Neurosci 8 (2007) 766-775
12. Calza L., Giardino L., and Ceccatelli S. NOS mRNA in the paraventricular nucleus of young and old rats after immobilization stress. Neuroreport 4 (1993) 627-630
13. Carrasco G.A., and Van De Kar L.D. Neuroendocrine pharmacology of stress. Eur J Pharmacol 463 (2003) 235-272
14. Charmandari E., Tsigos C., and Chrousos G. Endocrinology of the stress response. Annu Rev Physiol 67 (2005) 259-284
15. Connor T.J., Song C., Leonard B.E., Merali Z., and Anisman H. An assessment of the effects of central interleukin-1β, -2, -6, and tumor necrosis factor-α administration on some behavioural, neurochemical, endocrine and immune parameters in the rat. Neuroscience 84 (1998) 923-933
16. Costa A., Trainer P., Besser M., and Grossman A. Nitric oxide modulates the release of corticotropin-releasing hormone from the rat hypothalamus in vitro. Brain Res 605 (1993) 187-192
17. Cummings S., and Seybold V. Relationship of alpha-1- and alpha-2-adrenergic-binding sites to regions of the paraventricular nucleus of the hypothalamus containing corticotropin-releasing factor and vasopressin neurons. Neuroendocrinology 47 (1988) 523-532
18. Cunningham Jr. E.T., and Sawchenko P.E. Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus. J Comp Neurol 274 (1988) 60-76
19. Daftary S.S., Boudaba C., and Tasker J.G. Noradrenergic regulation of parvocellular neurons in the rat hypothalamic paraventricular nucleus. Neuroscience 96 (2000) 743-751
20. Dawson T.M., Bredt D.S., Fotuhi M., Hwang P.M., and Snyder S.H. Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues. Proc Natl Acad Sci U S A 88 (1991) 7797-7801
21. Day H.E.W., Campeau S., Watson Jr. S.J., and Akil H. Expression of α(1b) adrenoceptor mRNA in corticotropin-releasing hormones-containing cells of the rat hypothalamus and its regulation by corticosterone. J Neurosci 19 (1999) 10098-10106
22. Deak T., Bellamy C., and D'Agostino L.G. Exposure to forced swim stress does not alter central production of IL-1. Brain Res 972 (2003) 53-63
23. Deak T., Bordner K.A., McElderry N.K., Barnum C.J., Blandino Jr. P., Deak M.M., and Tammariello S.P. Stress-induced increases in hypothalamic IL-1: a systematic analysis of multiple stressor paradigms. Brain Res Bull 64 (2005) 541-556
24. De Kloet E.R., Joels M., and Holsboer F. Stress and the brain: from adaptation to disease. Nat Rev Neurosci 6 (2005) 463-475
25. De Oliveira R.M.W., Aparecida Del Bel E., Mamede-Rosa M.L.N., Padovan C.M., Deakin J.F.W., and Guimaraes F.S. Expression of neuronal nitric oxide synthase mRNA in stress-related brain areas after restraint in rats. Neurosci Lett 289 (2000) 123-126
26. Diana A., Van Dam A.M., Winblad B., and Schultzberg M. Co-localization of interleukin-1 receptor type I and interleukin-1 receptor antagonist with vasopressin in magnocellular neurons of the paraventricular and supraoptic nuclei of the rat hypothalamus. Neuroscience 89 (1999) 137-147
27. Ericsson A., Kovacs K.J., and Sawchenko P.E. A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons. J Neurosci 14 (1994) 897-913
28. Ericsson A., Liu C., Hart R.P., and Sawchenko P.E. Type 1 interleukin-1 receptor in the rat brain: distribution, regulation, and relationship to sites of IL-1-induced cellular activation. J Comp Neurol 361 (1995) 681-698
29. Fehm H.L., Voigt K.H., Lang R.E., and Pfeiffer E.F. Effects of neurotransmitters on the release of corticotropin releasing hormone (CRH) by rat hypothalamic tissue in vitro. Exp Brain Res 39 (1980) 229-234
30. Ferri C.C., and Ferguson A.V. Interleukin-1β depolarizes paraventricular nucleus parvocellular neurones. J Neuroendocrinol 15 (2003) 126-133
31. Gadek-Michalska A., and Bugajski J. Nitric oxide in the adrenergic- and CRH-induced activation of hypothalamic-pituitary-adrenal axis. J Physiol Pharmacol 59 (2008) 365-378
32. Gahwiler B.H., Capogna M., Debanne D., McKinney R.A., and Thompson S.M. Organotypic slice cultures: a technique has come of age. Trends Neurosci 20 (1997) 471-477
33. Garcia-Bueno B., Caso J.R., and Leza J.C. Stress as a neuroinflammatory condition in brain: damaging and protective mechanisms. Neurosci Biobehav Rev 32 (2008) 1136-1151
34. Goshen I., Yirmiya R., Iverfeldt K., and Weidenfeld J. The role of endogenous interleukin-1 in stress-induced adrenal activation and adrenalectomy-induced adrenocorticotropic hormone hypersecretion. Endocrinology 144 (2003) 4453-4458
35. Herman J.P., Cullinan W.E., Ziegler D.R., and Tasker J.G. Role of the paraventricular nucleus microenvironment in stress integration. Eur J Neurosci 16 3 (2002) 381-385
36. Hsieh C.H., and Li H.Y. Hypothalamic and hippocampal IL-1β expression induced by neurogenic stress (2002) Society for Neuroscience Meeting 32nd Annual Meeting; Orlando, FL
37. Hsieh C.H., and Li H.Y. Effects of noradrenaline and interleukin-1β on primary neuronal culture of rat hypothalamic neuroendocrine cells (2006) Society for Neuroscience Meeting 36th Annual Meeting; Atlanta, GA
38. Ignarro L.J., Napoli C., and Loscalzo J. Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview. Circ Res 90 (2002) 21-28
39. Ishizuka Y., Ishida Y., Jin Q.H., Kato K., Kunitake T., Mitsuyama Y., and Kannan H. Differential profiles of nitric oxide and norepinephrine releases in the paraventricular nucleus region in response to mild footshock in rats. Brain Res 862 (2000) 17-25
40. Itoi K., Helmreich D.L., Lopez-Figueroa M.O., and Watson S.J. Differential regulation of corticotropin-releasing hormone and vasopressin gene transcription in the hypothalamus by norepinephrine. J Neurosci 19 (1999) 5464-5472
41. Johnson J.D., Campisi J., Sharkey C.M., Kennedy S.L., Nickerson M., Greenwood B.N., and Fleshner M. Catecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines. Neuroscience 135 (2005) 1295-1307
42. Kim C.K., and Rivier C.L. Nitric oxide and carbon monoxide have a stimulatory role in the hypothalamic-pituitary-adrenal response to physico-emotional stressors in rats. Endocrinology 141 (2000) 2244-2253
43. Kishimoto J., Tsuchiya T., Emson P.C., and Nakayama Y. Immobilization-induced stress activates neuronal nitric oxide synthase (nNOS) mRNA and protein in hypothalamic-pituitary-adrenal axis in rats. Brain Res 720 (1996) 159-171
44. Lee S., Kim C.K., and Rivier C. Nitric oxide stimulates ACTH secretion and the transcription of the genes encoding for NGFI-B, corticotropin-releasing factor, corticotropin-releasing factor receptor type 1, and vasopressin in the hypothalamus of the intact rat. J Neurosci 19 (1999) 7640-7647
45. Li H.Y., and Sawchenko P.E. Hypothalamic effector neurons and extended circuitries activated in "neurogenic" stress: a comparison of footshock effects exerted acutely, chronically, and in animals with controlled glucocorticoid levels. J Comp Neurol 393 (1998) 244-266
46. Lightman S.L. The neuroendocrinology of stress: a never ending story. J Neuroendocrinol 20 (2008) 880-884
47. Little K.Y., Duncan G.E., Breese G.R., and Stumpf W.E. β-adrenergic receptor binding in human and rat hypothalamus. Biol Psychiatry 32 (1992) 512-522
48. Ludwig M., and Leng G. Dendritic peptide release and peptide-dependent behaviours. Nat Rev Neurosci 7 (2006) 126-136
49. Ludwig M., and Pittman Q.J. Talking back: dendritic neurotransmitter release. Trends Neurosci 26 (2003) 255-261
50. Maier S.F., and Watkins L.R. Intracerebroventricular interleukin-1 receptor antagonist blocks the enhancement of fear conditioning and interference with escape produced by inescapable shock. Brain Res 695 (1995) 279-282
51. Mancuso C., Tringali G., Grossman A., Preziosi P., and Navarra P. The generation of nitric oxide and carbon monoxide produces opposite effects on the release of immunoreactive interleukin-1β from the rat hypothalamus in vitro: evidence for the involvement of different signaling pathways. Endocrinology 139 (1998) 1031-1037
52. Martin M.U., and Falk W. The interleukin-1 receptor complex and interleukin-1 signal transduction. Eur Cytokine Netw 8 (1997) 5-17
53. Minami M., Kuraishi Y., Yamaguchi T., Nakai S., Hirai Y., and Satoh M. Immobilization stress induces interleukin-1β mRNA in the rat hypothalamus. Neurosci Lett 123 (1991) 254-256
54. Miyake S., Takahashi S.S., Yoshino F., Todoki K., Sasaguri K., Sato S., and Lee M.C.I. Nitric oxide levels in rat hypothalamus are increased by restraint stress and decreased by biting. Redox Report 13 (2008) 31-39
55. Muller M.B., Uhr M., Holsboer F., and Keck M.E. Hypothalamic-pituitary-adrenocortical system and mood disorders: highlights from mutant mice. Neuroendocrinology 79 (2004) 1-12
56. Nguyen K.T., Deak T., Owens S.M., Kohno T., Fleshner M., Watkins L.R., and Maier S.F. Exposure to acute stress induces brain interleukin-1β protein in the rat. J Neurosci 18 (1998) 2239-2246
57. Nguyen K.T., Deak T., Will M.J., Hansen M.K., Hunsaker B.N., Fleshner M., Watkins L.R., and Maier S.F. Timecourse and corticosterone sensitivity of the brain, pituitary, and serum interleukin-1β protein response to acute stress. Brain Res 859 (2000) 193-201
58. Pacak K., Armando I., Fukuhara K., Kvetnansky R., Palkovits M., Kopin I.J., and Goldstein D.S. Noradrenergic activation in the paraventricular nucleus during acute and chronic immobilization stress in rats: an in vivo microdialysis study. Brain Res 589 (1992) 91-96
59. Plotsky P.M. Facilitation of immunoreactive corticotropin-releasing factor secretion into the hypophysial-portal circulation after activation of catecholaminergic pathways or central norepinephrine injection. Endocrinology 121 (1987) 924-930
60. Plotsky P.M., Cunningham Jr. E.T., and Widmaier E.P. Catecholaminergic modulation of corticotropin-releasing factor and adrenocorticotropin secretion. Endocr Rev 10 (1989) 437-458
61. Risbrough V.B., and Stein M.B. Role of corticotropin releasing factor in anxiety disorders: a translational research perspective. Horm Behav 50 (2006) 550-561
62. Ritter S., Watts A.G., Dinh T.T., Sanchez-Watts G., and Pedrow C. Immunotoxin lesion of hypothalamically projecting norepinephrine and epinephrine neurons differentially affects circadian and stressor-stimulated corticosterone secretion. Endocrinology 144 (2003) 1357-1367
63. Sandi C., and Guaza C. Evidence for a role of nitric oxide in the corticotropin-releasing factor release induced by interleukin-1β. Eur J Pharmacol 274 (1995) 17-23
64. Sands S.A., and Morilak D.A. Expression of α(1D) adrenergic receptor messenger rna in oxytocin- and corticotropin-releasing hormone-synthesizing neurons in the rat paraventricular nucleus. Neuroscience 91 (1999) 639-649
65. Sapolsky R., Rivier C., and Yamamoto G. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 238 (1987) 522-524
66. Sawchenko P.E., and Swanson L.W. The organization and biochemical specificity of afferent projections to the paraventricular and supraoptic nuclei. Prog Brain Res 60 (1983) 19-29
67. Schmidt E.D., Aguilera G., Binnekade R., and Tilders F.J.H. Single administration of interleukin-1 increased corticotropin releasing hormone and corticotropin releasing hormone-receptor mRNA in the hypothalamic paraventricular nucleus which paralleled long-lasting (weeks) sensitization to emotional stressors. Neuroscience 116 (2003) 275-283
68. Schobitz B., De Kloet E.R., and Holsboer F. Gene expression and function of interleukin 1, interleukin 6 and tumor necrosis factor in the brain. Prog Neurobiol 44 (1994) 397-432
69. Seo D.O., and Rivier C. Microinfusion of a nitric oxide donor in discrete brain regions activates the hypothalamic-pituitary-adrenal axis. J Neuroendocrinol 13 (2001) 925-933
70. Silverman A.J., Hou-Yu A., and Chen W.P. Corticotropin-releasing factor synapses within the paraventricular nucleus of the hypothalamus. Neuroendocrinology 49 (1989) 291-299
71. Sims J.E., Gayle M.A., Slack J.L., Alderson M.R., Bird T.A., Giri J.G., Colotta F., Re F., Mantovani A., Shanebeck K., Grabstein K.H., and Dower S.K. Interleukin 1 signaling occurs exclusively via the type I receptor. Proc Natl Acad Sci U S A 90 (1993) 6155-6159
72. Smith S.M., and Vale W.W. The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress. Dialogues Clin Neurosci 8 (2006) 383-395
73. Stern J.E. Nitric oxide and homeostatic control: an intercellular signalling molecule contributing to autonomic and neuroendocrine integration?. Prog Biophys Mol Biol 84 (2004) 197-215
74. Stone E.A., and Zhang Y. Adrenoceptor antagonists block c-fos response to stress in the mouse brain. Brain Res 694 (1995) 279-286
75. Suda T., Tozawa F., Ushiyama T., Sumitomo T., Yamada M., and Demura H. Interleukin-1 stimulates corticotropin-releasing factor gene expression in rat hypothalamus. Endocrinology 126 (1990) 1223-1228
76. Tanaka M., Kohno Y., and Nakagawa R. Regional characteristics of stress-induced increases in brain noradrenaline release in rats. Pharmacol Biochem Behav 19 (1983) 543-547
77. Tanaka M., Tsuda A., Yokoo H., Yoshida M., Mizoguchi K., and Shimizu T. Psychological stress-induced increases in noradrenaline release in rat brain regions are attenuated by diazepam, but not by morphine. Pharmacol Biochem Behav 39 (1991) 191-195
78. Tilders F.J.H., and Schmidt E.D. Interleukin-1-induced plasticity of hypothalamic CRH neurons and long-term stress hyperresponsiveness. Ann N Y Acad Sci 840 (1998) 65-73
79. Tolias C.M., McNeil C.J., Kazlauskaite J., and Hillhouse E.W. Astrocytes rather than neurones mediate interleukin-1β dependent nitric oxide and superoxide radical release in primary hypothalamic rat cell cultures. Neurosci Lett 273 (1999) 57-60
80. Vale W., Spiess J., Rivier C., and Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin. Science 213 (1981) 1394-1397
81. Vermetten E., and Bremner J.D. Circuits and systems in stress. II. Applications to neurobiology and treatment in posttraumatic stress disorder. Depress Anxiety 16 (2002) 14-38
82. Vincent S.R., and Kimura H. Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience 46 (1992) 755-784
83. Vincent S.R. Nitric oxide: a radical neurotransmitter in the central nervous system. Prog Neurobiol 42 (1994) 129-160
84. Vutskits L., Bartanusz V., Schulz M.F., and Kiss J.Z. Magnocellular vasopressinergic neurons in explant cultures are rescued from cell death by ciliary neurotrophic factor and leukemia inhibiting factor. Neuroscience 87 (1998) 571-582
85. Watt J.A., and Hobbs N.K. Interleukin-1β immunoreactivity in identified neurons of the rat magnocellular neurosecretory system: evidence for activity-dependent release. J Neurosci Res 60 (2000) 478-489
86. Weidenfeld J., Feldman S., DeKeyser F.G., and Ovadia H. Effect of exogenous nitric oxide and inhibitors of nitric oxide synthase on the hypothalamic pituitary adrenal axis responses to neural stimuli. Neuroendocrinology 70 (1999) 153-159
87. Widmaier E.P., Lim A.T., and Vale W. Secretion of corticotropin-releasing factor from cultured rat hypothalamic cells: effects of catecholamines. Endocrinology 124 (1989) 583-590
88. Wittmann G. Regulation of hypophysiotrophic corticotrophin-releasing hormone- and thyrotrophin-releasing hormone-synthesising neurones by brainstem catecholaminergic neurones. J Neuroendocrinol 20 (2008) 952-960
89. Yayou K., Sato Y., Ito S., and Nakamura M. Comparison between the central effects of CRH and AVP in steers. Physiol Behav 93 (2008) 537-545